Represented Genentech in a Hatch-Waxman litigation concerning the drug Tamiflu®. Succeeded in overcoming an obviousness-type double patenting attack brought by generic drug company.
-
Co-Chair, Life Sciences; Chair, Patent Litigation & Counseling -
Partner